Reported in the Oct. 3, 2008 issue of Cell,
University of Wisconsin-Madison researchers, for the first time, have
found a messaging system in the brain that directly affects food intake
and body weight. The findings--from a study in mice--point to a completely new approach
to treating and preventing obesity in humans. The discovery also offers
hope for new ways to treat related disorders, such as type 2 diabetes
and cardiovascular diseases--the most prevalent health problems in the
United States and the rest of the developed world.
Led
by Dongsheng Cai, an assistant professor of physiology at the UW School
of Medicine and Public Health, the researchers looked specifically at
the hypothalamus--the brain structure responsible for maintaining a
steady state in the body--and for the first time found that a
cell-signaling pathway primarily associated with inflammation also
influences the regulation of food intake. Stimulating the pathway led
the animals to increase their energy consumption, while suppressing it
helped them maintain normal food intake and body weight.
The
research stems from recent explorations into the problem called
metabolic inflammation, a by-product of too much food or energy
consumption. Unlike the classical inflammation typically observed in
infections, injuries and diseases such as cancer, the metabolic
inflammation seen in obesity-related diseases is much milder, doesn't
lead to overt symptoms or cause tissues damage.
Metabolic
inflammation is a chronic, low-grade condition consisting of
inflammatory-like responses at the molecular level. It has many
downstream consequences, says Cai. It causes cellular dysfunction,
which can decrease the regulation of several physiological processes,
including metabolism.
Scientists believe that metabolic
inflammation may be at the core of many chronic, obesity-related
metabolic disorders that are so common today, he adds.
Cai
and his team zeroed in on NF-kappaB, a protein complex that can be
activated specifically by IKKbeta to induce inflammatory reactions in
many cell systems.
In earlier studies at Harvard, Cai
and colleagues found that the pathway interrupted sugar, fat or protein
metabolism in tissues where metabolism typically takes place--liver,
fat and skeletal muscle. Feeding mice high-sugar and high-fat diets
activated the pathway in these tissues.
Once he arrived
at the SMPH three years ago, Cai began to consider whether metabolic
inflammation might affect higher-up players in the central nervous
system, particularly the hypothalamus. This brain structure is a
critical master regulator of appetite and energy balance, and also
controls metabolism in the peripheral tissues he had studied before.
But nobody knew how the hypothalamus might contribute to the
development of metabolic diseases such as obesity and diabetes.
We
wanted to learn whether the pathway or pathways underlying metabolic
inflammation could affect metabolism regulators in the central nervous
system,╙ he says.
In the current study, Cai and his team
found first that IKKbeta/NF-kappaB does indeed exist in specific
neurons in the hypothalamus. The pathway is much more abundant in the
hypothalamus than in peripheral tissue, and it normally remains
inactive in the brain.
The researchers next showed that
over-nutrition through high-fat diet feeding activates
IKKbeta/NF-kappaB, specifically in neurons in the hypothalamus.
╥When
we knocked out the IKKbeta gene to suppress NF-kappaB activity in these
neurons, the animals were significantly protected from energy
over-consumption and obesity development, Cai says.
The
researchers also examined a cell component called the endoplasmic
reticulum (ER), shown recently to be involved in metabolic diseases
involving over-nutrition, to see if it might play a role in linking
over-nutrition to activate IKKbeta/NF-kappaB in the hypothalamus.
At
the intracellular level, when the ER is challenged with over-nutrition,
this leads to ER stress, which can push the IKKbeta/NF-kappaB pathway
to an active state, although the involved reactions could be quite
complicated, Cai says.
In several experiments, the
researchers found that ER stress caused by over-nutrition activated
IKKbeta/NF-kappaB in the hypothalamus. Suppressing ER stress in the
central nervous system significantly preserved normal regulation of
food intake and prevented obesity.
Cai says there╒s
still a lot of work to be done. His group has begun studying
IKKbeta/NF-kappaB connections to other pathways and regulations in the
hypothalamus.
The ultimate goal will certainly be to
identify a selective and effective suppressor of the pathway to target
related neurons, he says.
But Cai continues to look at
the big picture, seeking answers to questions such as: ╥How does the
environment connect to the genetics that seem to underlie the obesity
epidemic? What are the key steps that have led to the dramatic rise of
diabetes in the past three decades? and Why can╒t the body adjust to
changes that have occurred in the way people eat and what they eat?
About Obesity
Obesity
is a condition in which the natural energy reserve, stored in the fatty tissue
of humans and other mammals, exceeds healthy limits. It is commonly defined as
a body mass index (BMI) (weight divided by height squared) of
30 kg/m2 or higher.
Mortality is
increased in obesity,
with a BMI of over 32 being associated with a doubled risk of
death. Central obesity
(male-type or waist-predominant obesity,
characterized by a high waist-hip ratio), is an important risk factor for the metabolic syndrome, the clustering of a number of diseases
and risk factors that heavily predispose for cardiovascular disease. These are diabetes
mellitus, Type 2 diabetes mellitus, high blood pressure, high blood cholesterol, and triglyceride levels (combined
hyperlipidemia).
Apart from the
metabolic syndrome, obesity
is also correlated with a variety of other complications. For some of these
complaints, it has not been clearly established to what extent they are caused
directly by obesity
itself, or have some other cause (such as limited exercise)
that causes obesity
as well. The affected health conditions include but are not limited to:
- Cardiovascular: congestive heart failure, stroke, enlarged heart and its associated arrhythmias
and dizziness, varicose veins, and pulmonary embolism
- Endocrine: type 2 diabetes mellitus, insulin resistance, polycystic ovarian syndrome
(PCOS), menstrual disorders, and infertility
- Gastrointestinal: gastroesophageal
reflux disease (GERD), fatty liver disease, cholelithiasishernia, and colorectal cancer
- Renal and genitourinary: erectile dysfunction, urinary incontinence, chronic renal failure, hypogonadism (male), breast cancer (female), uterine cancer (female),
stillbirth
- Integument (skin and appendages):
stretch marks, acanthosis nigricans, lymphedema, cellulitis, carbuncles,
intertrigo
- Musculoskeletal:
hyperuricemia (which predisposes to gout), immobility, joint pain, osteoarthritis, low back pain
- Neurologic: stroke, meralgia paresthetica, headache, carpal tunnel syndrome, dementia, idiopathic intracranial hypertension
- Respiratory: obstructive sleep apnea, obesity hypoventilation
syndrome, asthma
- Psychological: depression, low self esteem, body dysmorphic disorder,
social stigmatization
- Erectile
Dysfunction
About
Heart Disease
Heart disease is a broad term that includes several more specific heart
conditions. These conditions include:
- Arrhythmias.
Irregular, or abnormally fast or slow, beating of the heart. The heart
beat is controlled by electrical impulses. When the timing or frequency of
these electrical impulses are disrupted, arrhythmias develop. Some
arrhythmias are quite serious. An example is ventricular fibrillation, a
severely abnormal heart rhythm that causes death unless treated right away
by providing an electrical shock to the heart (called defibrillation).
Others are less severe but can develop into more serious conditions over
time. A particular concern is atrial fibrillation. Atrial fibrillation is
rapid, irregular beating of the upper chambers of the heart. The chambers
can quiver instead of beating in a regular pattern. Blood is not fully
pumped out of them and may pool and clot.
- Cardiomyopathy. A weakening
of the heart muscle or a change in heart muscle structure. It often
results in inadequate heart pumping or other heart function abnormalities.
These can result from various causes, including prior heart attacks, viral
or bacterial infections, and others.
- Congenital Heart Disease.
Malformations of heart structures, present during pregnancy or at birth.
These may be caused by genetic factors or by adverse exposures during
pregnancy. Examples include holes in the walls that divide the heart
chambers, abnormal heart valves, and others. Congenital heart defects can
disrupt the normal flow of blood through the heart. Congenital heart
defects are the most common type of major birth defect.
- Coronary Heart Disease (CHD)/ Coronary Artery Disease (CAD). Coronary
artery disease (CAD), also called coronary heart disease (CHD) is a
narrowing of the small blood vessels that supply blood and oxygen to the
heart. CAD is the most common type of heart disease. CAD is the leading
cause of death in the United States for men and women. According to the
American Heart Association, more than 15 million people have some form of
the condition. Coronary artery disease is caused by any problem with the
coronary arteries that keeps the heart from getting enough oxygen- and
nutrient-rich blood. The most common cause is atherosclerosis which occurs
when fatty material and a substance called plaque builds up on the walls
of your arteries. This causes them to get narrow. As the coronary arteries
narrow, blood flow to the heart can slow down or stop The lack of
sufficient blood is called ischemia, so coronary artery disease is
sometimes called ischemic heart disease.
The lack of blood flow can cause chest pain (stable angina), shortness of
breath, irregular heart beats, called arrhythmias, and other
symptoms. Over time, CAD can weaken the heart muscle and lead to
heart failure, a serious problem where the heart cannot pump blood the way
that it should.
- Heart Attack. A
heart attack, also called a myocardial infarction may occur when blood
supply to the heart is severely reduced or completely blocked. When blood
flow is restricted the heart muscle cells do not receive enough oxygen and
begin to die. The more time that passes without treatment to restore blood
flow, the greater the damage to the heart. This damage can cause irregular
heart rhythms or even sudden cardiac arrest or stopping of the heart beat.
Death can result. Coronary artery disease is the chief underlying cause of
a heart attack. A less common cause of a heart attack is a severe spasm of
a coronary artery that reduces the blood supply to the heart.
- Heart Failure. This
may also be called congestive heart failure or chronic heart failure.
Heart failure is a condition where the heart cannot pump enough blood and
oxygen to meet the needs of other body organs. Heart failure does not mean
that the heart has stopped, but that it cannot pump blood the way that it
should. Heart failure is a serious condition. There is no cure for heart
failure at this time, except a heart transplant. Once diagnosed, medicines
are needed for the rest of the person's life. See our heart failure fact
sheet.
- Peripheral Arterial Disease
(PAD).
Hardening of the arteries that supply blood to the arms and legs. PAD is
usually the result of atherosclerosis, the buildup of plaque and narrowing
of the arteries. Blood flow and oxygen to the muscles in the arms and legs
can be reduced or even fully blocked. Painful leg muscles, numbness,
swelling in the ankles and feet, and weak pulse in the feet are some of
the signs and symptoms of PAD.
- Rheumatic
Heart Disease. This condition is damage to the heart
valves and other heart structures due to inflammation and scarring caused
by rheumatic fever, which occurs from streptococcal infection. Heart
disease is an umbrella term for a number of different diseases affecting
the heart. Heart disease is a number of abnormal conditions affecting the
heart and the blood vessels in the heart.
About Diabetes
Type 2 diabetes is also referred
to as non-insulin dependent diabetes mellitus
(NIDDM), or adult onset diabetes mellitus (AODM).
Type 2 diabetes affects nearly
21 million in the United States and nearly 200 million people worldwide.
Type 2 diabetes is characterized
by high levels of blood sugar, caused by the body's inability to utilize insulin
to move blood sugar into the cells for energy. In type 2 diabetes, patients can
still produce insulin, but do so relatively inadequately for their body's
needs, particularly in the face of insulin
resistance as discussed above. In many cases this actually means the
pancreas produces larger than normal quantities of insulin.
Diabetes is
a major cause of heart disease and stroke, as well as the
most common cause of blindness, kidney failure and amputations in U.S. adults.
|